Promoting and facilitating strategies to improve cardiovascular health worldwide
-
Conferences & Events
Organising high level conferences featuring presentations, seminars and discussions and attended by world-renowned consultants.
-
Webinars & e‑Learning
Specific training and best-practice modules, including ISCP on-demand webinars and ISCP-endorsed webinars
-
Expert Reviews & Analysis
Expert Reviews, Opinions and Brief Reports. Independent summary information to keep you up to date with the latest research.
-
Drug Interaction Database
A reference tool for cardiovascular physicians and surgeons, pharmacists, pharmacologists, scientists and medical practitioners.
ISCP Statement on the war in Ukraine The ISCP condemns the military aggression put forward by the leadership of the Russian Federation against Ukraine. With strong support from our colleagues, the ISCP urges for the aggression to cease and any conflict to be resolved on peaceful terms. The continued aggression against Ukraine by the leadership of the Russian Federation and Belarus has led the ISCP to temporarily exclude individuals based in the Russian Federation or in Belarus from active participation in any ISCP event or activity, including those being offered exclusively with a full membership. The ISCP very much regrets the effect this may have on physicians and allied healthcare professionals based in the Russian Federation and in Belarus. This should not be viewed as personal retaliation. However, the message to the leadership in these countries must be distinct and unequivocal.
A-Z of CV Pharmacotherapy:
ISCP Webinar Series
Our first five webinars produced in collaboration with our partners Radcliffe Cardiology are now available to view in the Webinars On Demand section:
1- Ferric Carboxymaltose: Ironing Out the Issues Around Heart Failure-Related Readmissions,
2- Inclisiran: A Jab Goes a Long Way,
3- Edoxaban: ENGAGEing in Individualisation of DOACs,
4- Valsartan Sacubitril: Has our PARADIGM shifted?,
5- Clopidogrel or Ticagrelor: Why, When, for Whom?, and
Details of future webinars will become available in Upcoming webinars very soon, including the next series of our own A to Z of CV Pharmacotherapy programme
Have you watched one or more of the above sessions? We value your opinion. Take 3 minutes to give us feedback on the series.
Upcoming Events
25
Aug
ESC Congress 2023
Conferences 25 Aug 2023
2
Nov
EuroCVP 2023
Conferences 02 Nov 2023
23
Nov
Highlights
The latest reviews, resources and expert analysis from our website.
newsfeed
Pegozafermin lowers high triglycerides, non-HDL and ApoB vs. placebo in small trial
Posted on June 09, 2023
Pegozafermin, a fibroblast growth factor 21 analog, reduced atherogenic particles in patients with severe hypertriglyceridemia and improved liver fat and insulin resistance... more
CAC screening, follow-up care lacking among Black patients in small study
Posted on June 09, 2023
Black patients who undergo coronary artery calcium scoring received less post-screening care and had more adverse CV events compared with white patients... more
Xenotransplantation: Are we ready for clinical trials in humans?
Posted on June 08, 2023
For this month’s Infectious Disease News cover story, we touched base with experts in transplant medicine and transplant infectious diseases to discuss... more
Addressing disparities in ASCVD within the US South Asian population
Posted on June 08, 2023
The South Asian population in the U.S. is one of the fastest-growing minority ethnic groups, and these individuals are a particularly higher-risk... more
ISCP book series
Current Cardiovascular Therapy
Kaski, Juan Carlos.
Series Editor: Juan Carlos Kaski Cardiovascular pharmacotherapy is a fast-moving and complex discipline within cardiology in general. New studies, trials and indications are appearing on a regular basis. This series created with the support of the International Society of Cardiovascular Pharmacotherapy (ISCP) is designed to establish the baseline level of knowledge that a cardiovascular professional needs to know on a day-to-day basis. The information within is designed to allow readers to learn quickly and with certainty the mode of action,...
-
Antiplatelet and Anticoagulation Therapy
A. Ferro, D.A. Garcia (Eds.)
-
Pharmacological Treatment of Acute Coronary Syndromes
Avanzas, Pablo; Clemmensen, Peter(Eds.)
-
Atrial Fibrillation Therapy
Gheorghe-Andrei Dan, Antoni Bayes de Luna, John Camm(Eds.)
board of directors
Providing a leadership and advocacy role amongst members of their national societies.
-
Alberto Lorenzatti
VP / President Elect
Affiliations/Memberships Founder and Past President of the Argentine Lipids Society (2003-2005); Current Chair of the Americas Federation from the International Atherosclerosis Society (IAS). Research Interests Atherosclerosis Lipid Metabolism Inflammation and CHD more
-
Pablo Avanzas
Secretary
Affiliations/Memberships Consultant in Invasive Cardiology, Hospital Universitario Central de Asturias, Oviedo, Spain Fellow of (more…) more
-
Sang Hong Baek
President
Professor Sang Hong Baek is Director of Heart Failure and Transplantation Programme and Preventive Cardiology at Seoul St. Mary's (more…) more
-
Georg Noll
Treasurer
Georg Noll is a specialist in General Internal Medicine and Cardiology at Heart Clinic Zurich. He was Associate Professor of Cardiology (more…) more